Full video transcriptClick to expand
Auto-generated transcript of @dr.mosaddeq_alyousif's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What is the argument?
- 0:00It is not that significant.
- 0:03It is because the question is very specific.
- 0:06At first, the question is that if we want to achieve the future of the year, we are going
- 0:10to work in our future.
- 0:12We want to have a future of future for 1, 3 or 4, 8.
- 0:16I am glad that we are doing that.
- 0:18I will work with you all the way to the future.
- 0:22In reality, when we do not even care about the future, we please be patient.
- 0:55and I will see you in the next video.
Peptide injection types: what the clinic video isn't telling you
Quick answer
The video promotes injectable peptides available at a clinic without specifying compounds, indications, patient selection criteria, or risks. The transcript contains no actionable medical information, making clinical evaluation of the spoken content impossible. Given the hashtag context around men's health and hormones, the likely products include GH secretagogues or tissue repair peptides, categories where human evidence is limited and regulatory status in many jurisdictions is actively contested.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptide injection types: what the clinic video isn't telling you, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
beta-Thymosins
Background source for thymosin biology and tissue-repair mechanisms.
PubMed
Thymosin beta 4 and the eye: the journey from bench to bedside
Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptide injection types: what the clinic video isn't telling you is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptide injection types: what the clinic video isn't telling you" from Dr. Mosaddeq Al-Yousif. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video promotes injectable peptides available at a clinic without specifying compounds, indications, patient selection criteria, or risks.
The reason this review is not generic is the source wording and the canonical claim label "peptides types of peptides available in our clinic peptides dr mosadd." In this clip, the useful excerpt is: "What is the argument?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video promotes injectable peptides available at a clinic without specifying compounds, indications, patient selection criteria, or risks.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video promotes injectable peptides available at a clinic without specifying compounds, indications, patient selection criteria, or risks. The transcript contains no actionable medical information, making clinical evaluation of the spoken content impossible. Given the hashtag context around men's health and hormones, the likely products include GH secretagogues or tissue repair peptides, categories where human evidence is limited and regulatory status in many jurisdictions is actively contested.
- The spoken transcript contains no factual medical claims about peptides, making direct fact-checking of stated content impossible.
- BPC-157 has no FDA-approved human indication and its tissue repair data comes almost entirely from rodent studies (Sikiric et al., 2018, Current Pharmaceutical Design).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The spoken transcript contains no factual medical claims about peptides, making direct fact-checking of stated content impossible.
- BPC-157 has no FDA-approved human indication and its tissue repair data comes almost entirely from rodent studies (Sikiric et al., 2018, Current Pharmaceutical Design).
- CJC-1295 combined with ipamorelin raises IGF-1 in adults per Teichman et al. (2006, JCEM), but IGF-1 elevation does not automatically produce the recovery or body composition outcomes marketed online.
- MK-677 increased lean mass in older adults in one trial (Nuttall et al., 2008, JCEM) but also raised fasting blood glucose, a risk rarely mentioned in clinic marketing.
- FDA guidance issued in 2023 and 2024 restricted multiple peptides previously available via compounding pharmacies, meaning the legal landscape for US-based peptide clinics has shifted significantly.
- TB-500 (thymosin beta-4) is prohibited by the World Anti-Doping Agency and has no approved human therapeutic use in most jurisdictions.
- Showing injectable vials to 15,500 viewers without disclosing risks, contraindications, or regulatory status is a transparency failure regardless of clinical intent.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @dr.mosaddeq_alyousif actually say?
Honestly? Not much that can be fact-checked. The transcript is largely incoherent, referencing "the future" repeatedly without making a single concrete medical claim about peptides. The caption advertises "types of peptides available in our clinic" but the spoken content doesn't name a single compound, mechanism, or protocol.
This appears to be a clinic promotional video, not an educational one. The hashtags point to men's health and hormones, and the visual context likely shows vials or syringes, but the audio provides almost nothing substantive to evaluate. When a provider shows injectable products on social media without explaining what they are, what they do, or who they're appropriate for, that's a red flag worth noting. Patients watching this aren't getting information. They're getting a sales pitch dressed up in a white coat aesthetic.
Does the science back this up?
There's nothing specific enough to evaluate here. But since the video is categorized under peptide therapy and the caption references peptides, it's worth grounding this in what the evidence actually shows for the category.
Peptides like BPC-157, TB-500, and CJC-1295 are frequently marketed for recovery, healing, and "optimization." BPC-157 has shown tissue repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but human clinical trial data remains thin. GH secretagogues like CJC-1295 combined with ipamorelin can raise IGF-1 levels in adults (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), but that doesn't automatically translate to the performance benefits commonly marketed online. MK-677, often grouped with peptides despite being a small molecule, showed muscle mass increases in older adults (Nuttall et al., 2008, Journal of Clinical Endocrinology and Metabolism) but also raised fasting glucose and increased appetite significantly. The science is real but it is early, contested, and nowhere near as clean as clinic marketing suggests.
What did they get wrong (or right)?
This is an unusual case. The creator didn't make verifiably wrong medical claims because they didn't make coherent medical claims at all. That's not a pass. It's a different kind of problem.
Showing injectable peptide vials to 15,500 viewers without explaining indications, risks, contraindications, or what regulatory status these compounds hold is irresponsible regardless of intent. Most peptides marketed in clinics like this are not FDA-approved for the uses being sold. BPC-157 has no approved human use. TB-500 (thymosin beta-4) is on the World Anti-Doping Agency prohibited list. Compounded peptides exist in a regulatory grey zone following FDA guidance updates in 2023 and 2024 that restricted several from compounding entirely.
The creator gets no credit for accuracy here because there's no accuracy to evaluate. They get a failing grade for transparency. If you're injecting something into a patient, that patient deserves more than a video about "the future."
What should you actually know?
Peptide therapy clinics are proliferating faster than the evidence base supporting them. That doesn't mean every peptide is useless. It means the gap between what's being sold and what's been proven is wide, and patients are the ones absorbing the risk.
A few things worth keeping in mind if you're considering a peptide clinic:
- Regulatory status matters. Several peptides previously available through compounding pharmacies were removed from the FDA's 503A and 503B bulk substances lists between 2023 and 2024, meaning legal access through US clinics has narrowed significantly.
- "Available in our clinic" is not a clinical recommendation. It is an inventory list.
- Injectable compounds carry real risks including infection at the injection site, immune reactions, and unknown long-term effects for compounds with no human trial data beyond a few years.
- A provider who markets to you via TikTok before you've had a consultation, labs, or a physical exam is prioritizing acquisition over care.
- Ask any peptide clinic to show you the peer-reviewed human trial data for what they're prescribing. Watch how they respond.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Mosaddeq Al-Yousif · TikTok creator
15.5K views on this video
اهي أنواع ابر البيتايد المتوفر في عيادتنا ظtypes of peptides available in our clinic #peptidesصحة_الرجال #dr_mosaddeq_alyousif #hormones
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the spoken transcript contains no factual medical claims about peptides,?
The spoken transcript contains no factual medical claims about peptides, making direct fact-checking of stated content impossible.
What does the video say about bpc-157 has no fda-approved human indication?
BPC-157 has no FDA-approved human indication and its tissue repair data comes almost entirely from rodent studies (Sikiric et al., 2018, Current Pharmaceutical Design).
What does the video say about cjc-1295 combined with ipamorelin raises igf-1 in adults per teichman?
CJC-1295 combined with ipamorelin raises IGF-1 in adults per Teichman et al. (2006, JCEM), but IGF-1 elevation does not automatically produce the recovery or body composition outcomes marketed online.
What does the video say about mk-677 increased lean mass in older adults in one trial?
MK-677 increased lean mass in older adults in one trial (Nuttall et al., 2008, JCEM) but also raised fasting blood glucose, a risk rarely mentioned in clinic marketing.
What does the video say about fda guidance?
FDA guidance issued in 2023 and 2024 restricted multiple peptides previously available via compounding pharmacies, meaning the legal landscape for US-based peptide clinics has shifted significantly.
What does the video say about tb-500 (thymosin beta-4)?
TB-500 (thymosin beta-4) is prohibited by the World Anti-Doping Agency and has no approved human therapeutic use in most jurisdictions.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Mosaddeq Al-Yousif, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.